Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2005
03/10/2005US20050053944 Using microarray comprised of immobilized peptide nucleic acids as probes for detection of preferential DNA or RNA target sequences
03/10/2005US20050053943 Transmembrane protein for use in the diagnosis, detection, prevention and treatment of cell proliferative disorders; immunotherapy
03/10/2005US20050053942 Using locked nucleic acids as tools in detection of homopolymeric sequences; genomic analysis; detecting viral nucleotide sequences
03/10/2005US20050053941 Extraction of nucleic acid
03/10/2005US20050053940 Mutant huntingtin polypeptide for use in identifying modulator for treatment of nervous system disorders
03/10/2005US20050053938 Identifying modulators for treatmet and prevention cell proliferative, blood, reproductive, respiratoty and urogenital disorders; enzyme inhibitors
03/10/2005US20050053936 High-throughput transcriptome and functional validation analysis
03/10/2005US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
03/10/2005US20050053934 Method of selecting barley variety, barley beta-amylase gene and process for producing malt alcoholic drink
03/10/2005US20050053933 Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof
03/10/2005US20050053932 Novel stress-associated genetic products from ashbya gossypii
03/10/2005US20050053931 Method for the diagnosis and therapy of renal cell carcinoma
03/10/2005US20050053929 Using transposase transgenesis as tool in correlating phenotype and genic action
03/10/2005US20050053927 Rifamycin biosynthesis gene cluster
03/10/2005US20050053926 Nucleic Acid displacer compositions and cells comprising same
03/10/2005US20050053925 Epitopes; immunoglobulins; hybridomas; diagnostic kits
03/10/2005US20050053924 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
03/10/2005US20050053922 Expression vector comprising nucleotide sequences coding mutated cap and rep viral proteins for use as gene transfer tools in heterologous gene expression; RNA interference
03/10/2005US20050053921 Systems for screening anti-hepatitis drugs
03/10/2005US20050053920 Retrovirus from the HIV group and its use
03/10/2005US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection
03/10/2005US20050053914 Nucleotide sequences coding hepatitis envelope protein for use as tool in detecting hepactocyte receptors; drug screening, viricides and treatment of viral diseases
03/10/2005US20050053913 Reverse two-hybrid systems
03/10/2005US20050053622 Protecting cats against feline infectious peritonitis (FIP); fragments of an S protein of coronavirus
03/10/2005US20050053620 Recombinant vaccinia virus vaccine
03/10/2005US20050053610 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
03/10/2005US20050053607 Proteins for treatment of cancer by administering antinucleolin
03/10/2005US20050053606 MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom
03/10/2005US20050053601 Protein with amino acid sequences for central nervous systems in mammals
03/10/2005US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
03/10/2005US20050053591 Reagents and method of transport of macromolecules for drug therapyincluding nucleic acids
03/10/2005US20050053590 Endothelium-targeting nanoparticle for reversing endothelial dysfunction
03/10/2005US20050053588 Conversion of liver stem and progenitor cells to pancreatic functional cells
03/10/2005US20050053583 Method of inhibiting prion protein
03/10/2005US20050053581 Which effect p53 binding/inactivation; enhances efficacy of such viruses for treating cancer; liposomes
03/10/2005US20050053580 Antisense oligonucleotides, stabilized ribozymes, aptamers, mirror aptamers, chimeric RNA/DNA oligonucleotides, naked plasmid-DNA or liposomally encapsulated DNA which code for androgen receptor and/or the testosterone 5 alpha-reductase; sebocytes; keratinocytes
03/10/2005US20050053575 Antigenic product displaying multiple copies of an epitope of a deposit-forming polypeptide involved in plaque-forming diseases and methods of using same
03/10/2005US20050050767 Wet chemical processing chambers for processing microfeature workpieces
03/10/2005CA2548483A1 Induction of antiviral neutralizing antibodies in humans and animals
03/10/2005CA2543605A1 Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins
03/10/2005CA2537505A1 Citrus sesquiterpene synthase, methods of production and uses thereof
03/10/2005CA2537179A1 Anti-angiogenic peptides from the n-terminus of endostatin
03/10/2005CA2537151A1 Novel vector and utilization of the same
03/10/2005CA2537140A1 Gastric and prostate cancer associated antigens
03/10/2005CA2537115A1 Methods for the early diagnosis of ovarian cancer
03/10/2005CA2537105A1 A process for proteolytic cleavage and purification of recombinant proteins produced in plants
03/10/2005CA2537102A1 A process for proteolytic cleavage and purification of recombinant proteins produced in plants
03/10/2005CA2537099A1 Modulation of .beta.-catenin/tcf activated transcription
03/10/2005CA2536912A1 Combination therapy for the treatment of ocular neovascular disorders
03/10/2005CA2536911A1 Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor
03/10/2005CA2536873A1 Poly-pegylated protease inhibitors
03/10/2005CA2536866A1 Promoter of the human fatp5 gene and uses
03/10/2005CA2536599A1 Method of constructing transgenic bird using lentivirus vector and transgenic bird obtained thereby
03/10/2005CA2536471A1 Aav vectors for in vivo gene therapy of rheumatoid arthritis
03/10/2005CA2536467A1 Method for detoxification of mycotoxins
03/10/2005CA2536333A1 Interfering rna duplex having blunt-ends and 3'-modifications
03/10/2005CA2536324A1 Hepatocellular cancer-associated gene
03/10/2005CA2536205A1 Human obesity susceptibility gene and uses thereof
03/10/2005CA2536191A1 Nanoparticles for delivery of nucleic acids and stable double-stranded rna
03/10/2005CA2535902A1 Uses of spatial configuration to modulate protein function
03/10/2005CA2535816A1 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders
03/10/2005CA2535526A1 Laccases, nucleic acids encoding them and methods for making and using them
03/10/2005CA2535522A1 Fsh glycosylation mutant
03/10/2005CA2535310A1 Fatty acid desaturases from primula
03/10/2005CA2533572A1 Estimation of activity or inhibition of processes involved in nucleic acid modification using chemiluminescence quenching
03/10/2005CA2532973A1 Ion channel assay methods
03/10/2005CA2530350A1 Digital cell
03/10/2005CA2529710A1 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
03/10/2005CA2526128A1 Severe acute respiratory syndrome dna vaccine compositions and methods of use
03/09/2005EP1512754A1 Detection reagent for thermostable direct hemolysin gene of vibrio parahaemolyticus
03/09/2005EP1512753A1 Detection reagent for thermostable direct hemolysin-related hemolysin gene of Vibrio parahaemolyticus
03/09/2005EP1512749A2 DNA to be introduced into biogenic gene, gene introducing vector, cell, and method for introducing information into biogenic gene
03/09/2005EP1512748A1 O-methyltransferases of tetrahydrobenzylisoquinoline alkaloid biosynthesis in papaver somniferum
03/09/2005EP1512747A1 Gene encoding glutathione synthetase from candida utilis
03/09/2005EP1512746A1 Method for the production of a polypeptide, RNA or other compound in tumor tissue
03/09/2005EP1512745A1 Pigment protein
03/09/2005EP1512744A1 Pigment protein
03/09/2005EP1512743A1 Conditional modification of siRNAs expression
03/09/2005EP1512742A1 Conditional modification of sirnas expression
03/09/2005EP1512741A2 A method for separation and purification of nucleic acid
03/09/2005EP1512697A1 TNF Receptor action modulation
03/09/2005EP1512696A1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
03/09/2005EP1512695A1 Hypoallergenic polypeptides based on fish parvalbumin
03/09/2005EP1512694A1 Wasp venom allergens with reduced IgE-reactivity
03/09/2005EP1512693A2 Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof
03/09/2005EP1512415A1 Decoy composition for treating and preventing inflammatory disease
03/09/2005EP1512014A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
03/09/2005EP1512013A2 Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases
03/09/2005EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
03/09/2005EP1511864A2 Viral capsid assembly intermediates
03/09/2005EP1511860A1 Improvements in and relating to a method of dna testing for------mycobacterium paratuberculosis strains
03/09/2005EP1511858A1 In vitro screening of cellular events using 3d cell culture systems
03/09/2005EP1511857A1 Pthrp-based prediction and diagnosis of bone disease
03/09/2005EP1511856A1 Method for parallelly sequencing a nucleic acid mixture by using a continuous flow system
03/09/2005EP1511855A2 Expression profile of prostate cancer
03/09/2005EP1511853A2 Regulation of novel human asparagine-hydroxylases
03/09/2005EP1511850A1 Methods of treating and diagnosing diabetes with cx3cr1 modulators
03/09/2005EP1511847A1 Reporter system for plants
03/09/2005EP1511846A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
03/09/2005EP1511845A2 Immunostimulatory oligonucleotides and uses thereof
1 ... 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 ... 4023